5月15日,新华制药参与2025年山东辖区上市公司投资者网上集体接待日。期间管理层披露,在创新药领域已构建多个大研发平台(如新型给药系统、小分子创新等),OAB-14(用于阿尔茨海默病治疗)等创新药物进展顺利,目前处于二期临床前准备过程中。未来公司将持续强化研发投入,依托院士团队、校企合作等加快创新药研发和新产品投产转化,推动形成公司新的利润增长点。有投资者质疑,正常经营中,管理费用和销售费用相对...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.